Oxidative stress in human infectious diseases - present and current - knowledge about its druggability (2013)
- Authors:
- Autor USP: WRENGER, CARSTEN - ICB
- Unidade: ICB
- Subjects: FARMÁCOS; PRODUTOS NATURAIS; DOENÇAS INFECIOSAS; ESTRESSE OXIDATIVO
- Language: Inglês
- Imprenta:
- Publisher: In Tech
- Publisher place: Rijeka, Croatia
- Date published: 2013
- ISBN: 9789535109068
- Source:
- Título do periódico: Drug discovery
-
ABNT
WRENGER, Carsten e SCHETTER, Isolmar e LIEBAU, Eva. Oxidative stress in human infectious diseases - present and current - knowledge about its druggability. Drug discovery. Tradução . Rijeka, Croatia: In Tech, 2013. . Disponível em: http://www.intechopen.com/books/drug-discovery. Acesso em: 19 abr. 2024. -
APA
Wrenger, C., Schetter, I., & Liebau, E. (2013). Oxidative stress in human infectious diseases - present and current - knowledge about its druggability. In Drug discovery. Rijeka, Croatia: In Tech. Recuperado de http://www.intechopen.com/books/drug-discovery -
NLM
Wrenger C, Schetter I, Liebau E. Oxidative stress in human infectious diseases - present and current - knowledge about its druggability [Internet]. In: Drug discovery. Rijeka, Croatia: In Tech; 2013. [citado 2024 abr. 19 ] Available from: http://www.intechopen.com/books/drug-discovery -
Vancouver
Wrenger C, Schetter I, Liebau E. Oxidative stress in human infectious diseases - present and current - knowledge about its druggability [Internet]. In: Drug discovery. Rijeka, Croatia: In Tech; 2013. [citado 2024 abr. 19 ] Available from: http://www.intechopen.com/books/drug-discovery - Cytometric quantification of singlet oxygen in the human malaria parasite Plasmodium falciparum
- Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target?
- The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation
- Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but... how to deal with them?
- Chemical and genetic validation of thiamine utilization as an antimalarial drug target
- Harnessing the helminth secretome for therapeutic immunomodulators
- MRSA infections: from classical treatment to suicide drugs
- Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles
- Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro
- Structure of ThiM from Vitamin B1 biosynthetic pathway of Staphylococcus aureus – Insights into a novel pro-drug approach addressing MRSA infections
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas